HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhicheng Lin Selected Research

Therapeutics

6/2022Pearson's patterns correlational of clinical risks at admissions with hospitalization outcomes during initial COVID-19 outbreak.
3/2022Measurement of the Photothermal Conversion Efficiency of CNT Films Utilizing a Raman Spectrum.
1/2020Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review.
1/2015Effectiveness of traditional Chinese medicine as an adjunct therapy for Parkinson's disease: a systematic review and meta-analysis.
4/2014Effects of Alisma Decoction on lipid metabolism and inflammatory response are mediated through the activation of the LXRα pathway in macrophage-derived foam cells.
9/2013bFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhicheng Lin Research Topics

Disease

24Parkinson Disease (Parkinson's Disease)
07/2022 - 05/2003
7COVID-19
06/2022 - 01/2020
5Substance-Related Disorders (Drug Abuse)
10/2019 - 12/2004
4Schizophrenia (Dementia Praecox)
05/2016 - 04/2004
4Stroke (Strokes)
08/2014 - 01/2011
4Brain Ischemia (Cerebral Ischemia)
01/2014 - 10/2012
3Inflammation (Inflammations)
07/2022 - 08/2012
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 04/2014
3Ischemic Stroke
01/2014 - 10/2012
2Alcoholism (Alcohol Abuse)
01/2022 - 07/2011
2Movement Disorders (Movement Disorder)
01/2022 - 08/2019
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2022 - 04/2004
2Cognitive Dysfunction
01/2021 - 08/2014
2Mental Disorders (Mental Disorder)
01/2019 - 01/2011
2Cerebral Infarction
03/2016 - 10/2012
2Dyskinesias (Dyskinesia)
01/2016 - 11/2006
2Mitochondrial Diseases (Mitochondrial Disease)
11/2015 - 08/2012
2Brain Diseases (Brain Disorder)
01/2014 - 01/2011
1Chronobiology Disorders (Circadian Rhythm Disorder)
07/2022
1Neoplasms (Cancer)
03/2022
1Autistic Disorder (Autism)
01/2022
1Dementia (Dementias)
06/2021
1Coronavirus Infections
06/2021
1Alzheimer Disease (Alzheimer's Disease)
06/2021
1Infections
06/2021
1Pneumonia (Pneumonitis)
02/2021
1Pain (Aches)
12/2017
1Ischemia
03/2016
1Wounds and Injuries (Trauma)
11/2015
1Atherosclerosis
04/2014
1Cocaine-Related Disorders (Cocaine Addiction)
01/2014
1Reperfusion Injury
06/2013
1Spinal Cord Injuries (Spinal Cord Injury)
04/2013
1Epilepsy (Aura)
04/2013
1Neuroblastoma
03/2013
1Catalepsy
01/2011
1Carcinogenesis
11/2010

Drug/Important Bio-Agent (IBA)

10Dopamine (Intropin)FDA LinkGeneric
11/2020 - 05/2003
8RotenoneIBA
11/2015 - 11/2009
7Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2019 - 11/2006
6Neuroprotective AgentsIBA
11/2015 - 04/2004
4Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2011
4Cocaine (Cocaine HCl)IBA
01/2021 - 05/2003
3SynucleinsIBA
01/2019 - 08/2012
2Therapeutic UsesIBA
02/2021 - 01/2020
2AntioxidantsIBA
07/2019 - 08/2012
2CytokinesIBA
07/2019 - 04/2014
2AcidsIBA
03/2016 - 04/2013
2Glutamic Acid (Glutamate)FDA Link
04/2013 - 08/2012
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
07/2022
1MelatoninIBA
07/2022
1Carbon Nanotubes (Carbon Nanotube)IBA
03/2022
1Apolipoprotein E4IBA
06/2021
1Protein Isoforms (Isoforms)IBA
06/2021
1Apolipoproteins E (ApoE)IBA
06/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Nucleic AcidsIBA
01/2021
1Transcription Factors (Transcription Factor)IBA
10/2019
1Biological ProductsIBA
07/2019
1Genetic Markers (Genetic Marker)IBA
01/2019
1Cytoskeletal ProteinsIBA
01/2017
1GABA-B Receptor AntagonistsIBA
03/2016
1salicylhydroxamic acid (SHAM)IBA
03/2016
1ElementsIBA
03/2016
1ChloridesIBA
03/2016
1Carrier Proteins (Binding Protein)IBA
03/2016
1Adenosine (Adenocard)FDA LinkGeneric
03/2016
1GABA-B ReceptorsIBA
03/2016
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
03/2016
1fenpropathrinIBA
03/2016
1Levodopa (L Dopa)FDA LinkGeneric
01/2016
1LithiumIBA
11/2015
1Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA
01/2015
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
04/2014
1LipidsIBA
04/2014
1Liver X ReceptorsIBA
04/2014
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
04/2014
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2013
1AMPA Receptors (AMPA Receptor)IBA
04/2013
1gua lou gui zhiIBA
04/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2013
1Glucosylceramidase (Glucocerebrosidase)IBA
12/2012
1Nerve Growth Factors (Neurotrophins)IBA
08/2012
1Amyloid beta-PeptidesIBA
08/2012
13-n-butylphthalide (butylphthalide)IBA
08/2012
1PesticidesIBA
08/2012
1CalciumIBA
08/2012
1Messenger RNA (mRNA)IBA
01/2011
1EdaravoneIBA
01/2011
1DNA (Deoxyribonucleic Acid)IBA
01/2011
1Free Radical ScavengersIBA
01/2011
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2011
1Serotonin (5 Hydroxytryptamine)IBA
01/2011

Therapy/Procedure

6Therapeutics
06/2022 - 09/2013
2Electroacupuncture
06/2013 - 10/2012
2Acupuncture Points (Acupuncture Point)
06/2013 - 10/2012
1Length of Stay
01/2020
1Percutaneous Collagen Induction
03/2016
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2015
1Cognitive Training
08/2014